BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment von Winter, Georg E., Mayer, Andreas, Buckley, Dennis L., Erb, Michael A., Roderick, Justine E., Vittori, Sarah, Reyes, Jaime M., di Iulio, Julia, Souza, Amanda, Ott, Christopher J., Roberts, Justin M., Zeid, Rhamy, Scott, Thomas G., Paulk, Joshiawa, Lachance, Kate, Olson, Calla M., Dastjerdi, Shiva, Bauer, Sophie, Lin, Charles Y., Gray, Nathanael S., Kelliher, Michelle A., Churchman, L. Stirling, Bradner, James E.

Volltext

Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype von Olson, Calla M., Liang, Yanke, Leggett, Alan, Park, Woojun D., Li, Lianbo, Mills, Caitlin E., Elsarrag, Selma Z., Ficarro, Scott B., Zhang, Tinghu, Düster, Robert, Geyer, Matthias, Sim, Taebo, Marto, Jarrod A., Sorger, Peter K., Westover, Ken D., Lin, Charles Y., Kwiatkowski, Nicholas, Gray, Nathanael S.

Volltext

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer von Bowling, Elizabeth A., Wang, Jarey H., Gong, Fade, Wu, William, Neill, Nicholas J., Kim, Ik Sun, Tyagi, Siddhartha, Orellana, Mayra, Kurley, Sarah J., Dominguez-Vidaña, Rocio, Chung, Hsiang-Ching, Hsu, Tiffany Y.-T., Dubrulle, Julien, Saltzman, Alexander B., Li, Heyuan, Meena, Jitendra K., Canlas, Gino M., Chamakuri, Srinivas, Singh, Swarnima, Simon, Lukas M., Olson, Calla M., Dobrolecki, Lacey E., Lewis, Michael T., Zhang, Bing, Golding, Ido, Rosen, Jeffrey M., Young, Damian W., Malovannaya, Anna, Stossi, Fabio, Miles, George, Ellis, Matthew J., Yu, Lihua, Buonamici, Silvia, Lin, Charles Y., Karlin, Kristen L., Zhang, Xiang H.-F., Westbrook, Thomas F.

Volltext

Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors von Richters, André, Doyle, Shelby K., Freeman, David B., Lee, Christina, Leifer, Becky S., Jagannathan, Sajjeev, Kabinger, Florian, Koren, Jošt Vrabič, Struntz, Nicholas B., Urgiles, Julie, Stagg, Ryan A., Curtin, Brice H., Chatterjee, Deep, Mathea, Sebastian, Mikochik, Peter J., Hopkins, Tamara D., Gao, Hua, Branch, Jonathan R., Xin, Hong, Westover, Lori, Bignan, Gilles C., Rupnow, Brent A., Karlin, Kristen L., Olson, Calla M., Westbrook, Thomas F., Vacca, Joseph, Wilfong, Chris M., Trotter, B. Wesley, Saffran, Douglas C., Bischofberger, Norbert, Knapp, Stefan, Russo, Joshua W., Hickson, Ian, Bischoff, James R., Gottardis, Marco M., Balk, Steven P., Lin, Charles Y., Pop, Marius S., Koehler, Angela N.

Volltext

ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma von Arabzade, Amir, Zhao, Yanhua, Varadharajan, Srinidhi, Chen, Hsiao-Chi, Jessa, Selin, Rivas, Bryan, Stuckert, Austin J., Solis, Minerva, Kardian, Alisha, Tlais, Dana, Golbourn, Brian J., Stanton, Ann-Catherine J., Chan, Yuen San, Olson, Calla, Karlin, Kristen L., Kong, Kathleen, Kupp, Robert, Hu, Baoli, Injac, Sarah G., Ngo, Madeline, Wang, Peter R., De Leon, Luz A., Sahm, Felix, Kawauchi, Daisuke, Pfister, Stefan M., Lin, Charles Y., Hodges, H. Courtney, Singh, Irtisha, Westbrook, Thomas F., Chintagumpala, Murali M., Blaney, Susan M., Parsons, Donald W., Pajtler, Kristian W., Agnihotri, Sameer, Gilbertson, Richard J., Yi, Joanna, Jabado, Nada, Kleinman, Claudia L., Bertrand, Kelsey C., Deneen, Benjamin, Mack, Stephen C.

Volltext

IRF2 is a master regulator of human keratinocyte stem cell fate von Mercado, Nicolas, Schutzius, Gabi, Kolter, Christian, Estoppey, David, Bergling, Sebastian, Roma, Guglielmo, Gubser Keller, Caroline, Nigsch, Florian, Salathe, Adrian, Terranova, Remi, Reece-Hoyes, John, Alford, John, Russ, Carsten, Knehr, Judith, Hoepfner, Dominic, Aebi, Alexandra, Ruffner, Heinz, Beck, Tanner C., Jagannathan, Sajjeev, Olson, Calla M., Sheppard, Hadley E., Elsarrag, Selma Z., Bouwmeester, Tewis, Frederiksen, Mathias, Lohmann, Felix, Lin, Charles Y., Kirkland, Susan

Volltext

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors von Zhang, Tinghu, Kwiatkowski, Nicholas, Olson, Calla M, Dixon-Clarke, Sarah E, Abraham, Brian J, Greifenberg, Ann K, Ficarro, Scott B, Elkins, Jonathan M, Liang, Yanke, Hannett, Nancy M, Manz, Theresa, Hao, Mingfeng, Bartkowiak, Bartlomiej, Greenleaf, Arno L, Marto, Jarrod A, Geyer, Matthias, Bullock, Alex N, Young, Richard A, Gray, Nathanael S

Volltext

The insulin receptor cellular IRES confers resistance to eIF4A inhibition von Olson, Calla M, Donovan, Marissa R, Spellberg, Michael J, Marr, 2nd, Michael T

Volltext

Determinants at the N- and C-termini of Gα12 required for activation of Rho-mediated signaling von Ritchie, Benjamin J, Smolski, William C, Montgomery, Ellyn R, Fisher, Elizabeth S, Choi, Tina Y, Olson, Calla M, Foster, Lori A, Meigs, Thomas E

Volltext

MODL-12. REPURPOSING SSRI/SNRI TARGETING NEUROTRANSMITTER SIGNALING TO SENSITIZE DMG TO CDK9 INHIBITORS von Murdaugh, Rebecca L, Eberl, Brittany R, Richard, Rosemary U, Tremblay, Jack R, Dei-Ampeh, Alfred, Olson, Calla M, Anastas, Jamie N

Volltext

A broad-spectrum antiviral molecule, QL47, selectively inhibits eukaryotic translation von de Wispelaere, Mélissanne, Carocci, Margot, Burri, Dominique J, Neidermyer, Jr, William J, Olson, Calla M, Roggenbach, Imme, Liang, Yanke, Wang, Jinhua, Whelan, Sean P J, Gray, Nathanael S, Yang, Priscilla L

Volltext

BIOCHEMICAL SELECTIVITY PROFILING AGAINST RNA HELICASES von Westbrook, Thomas F, Olson, Calla, Karlin, Kristen

Volltext bestellen

CELLULAR SELECTIVITY PROFILING AGAINST RNA HELICASES AND SPLICING REGULATORS von OLSON, Calla, WESTBROOK, Thomas F, KARLIN, Kristen

Volltext bestellen

Determinants at the N- and C-termini of G[alpha].sub.12 required for activation of Rho-mediated signaling von Ritchie, Benjamin J, Smolski, William C, Montgomery, Ellyn R, Fisher, Elizabeth S, Choi, Tina Y, Olson, Calla M, Foster, Lori A, Meigs, Thomas E

Volltext

BIOCHEMICAL SELECTIVITY PROFILING AGAINST RNA HELICASES von OLSON, Calla, WESTBROOK, Thomas F, KARLIN, Kristen

Volltext bestellen

DEGRADATION OF CYCLIN-DEPENDENT KINASE 8 (CDK8) BY CONJUGATION OF CDK8 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE von KWIATKOWSKI, Nicholas, OLSON, Calla M, ZHANG, Tinghu, LIANG, Yanke, GRAY, Nathanael

Volltext bestellen

DEGRADATION OF CYCLIN-DEPENDENT KINASE 8 (CDK8) BY CONJUGATION OF CDK8 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE von Gray, Nathanael S, Olson, Calla M, Zhang, Tinghu, Kwiatkowski, Nicholas, Liang, Yanke

Volltext bestellen

DEGRADATION OF CYCLIN-DEPENDENT KINASE 4/6 (CDK4/6) BY CONJUGATION OF CDK4/6 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE von GRAY, Nathanael S, JIANG, Baishan, KWIATKOWSKI, Nicholas, OLSON, Calla M, ZHANG, Tinghu, LIANG, Yanke, WANG, Eric

Volltext bestellen

DEGRADATION OF CYCLIN-DEPENDENT KINASE 9 (CDK9) BY CONJUGATION OF CDK9 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE von KWIATKOWSKI, Nicholas, OLSON, Calla M, ZHANG, Tinghu, LIANG, Yanke, GRAY, Nathanael

Volltext bestellen

Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use von Gray, Nathanael S, Olson, Calla M, Zhang, Tinghu, Kwiatkowski, Nicholas, Liang, Yanke

Volltext bestellen